Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

944
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
944
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.2K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

643
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
643
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

698
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
698
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

436
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
436
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

321
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
321

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel flowable calcium silicate cement for endodontic therapy in equine teeth.

Equine veterinary journal·2026
Same author

Conditioned Food Avoidance and Sensitivity Theory (C-FAST)- A Novel Conceptual Framework to Understand Food Sensitivity Fear.

Neurogastroenterology and motility·2026
Same author

Efficacy and tolerability of native (undenatured) type II collagen supplementation for joint health in healthy volunteers: a randomized double-blind placebo-controlled study.

Nutrition journal·2026
Same author

Pilot testing of the Research Impact Assessment Framework.

Australian health review : a publication of the Australian Hospital Association·2025
Same author

The Discovery, Characterization, and Quantification of Bioactive Peptides Contained in Palbio Porcine Intestinal Mucosa Hydrolysate Products.

International journal of molecular sciences·2025
Same author

A Novel Sprayable Fibrinogen/Glycosaminoglycans/Collagen-Based Bioink for Skin Wound Healing Applied by a Handheld Dual-Head Airbrush.

Advanced healthcare materials·2025

Related Experiment Video

Updated: Jan 16, 2026

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
08:25

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Published on: April 27, 2021

2.7K

Evidence for Dietary Management of Histamine Intolerance.

Kirsten Jackson1, Wendy Busse2, Patricia Gálvez-Martín3

  • 1The IBS Dietitian.

International Journal of Molecular Sciences
|September 27, 2025
PubMed
Summary
This summary is machine-generated.

Histamine intolerance (HIT) affects many, causing symptoms due to impaired histamine breakdown by diamine oxidase (DAO). Dietary changes and DAO supplements show promise for managing HIT symptoms.

Keywords:
diamine oxidase (DAO)food intolerancehistaminehistamine intolerance

More Related Videos

Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation
04:34

Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation

Published on: September 14, 2018

26.5K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.3K

Related Experiment Videos

Last Updated: Jan 16, 2026

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
08:25

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Published on: April 27, 2021

2.7K
Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation
04:34

Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation

Published on: September 14, 2018

26.5K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.3K

Area of Science:

  • Gastroenterology
  • Immunology
  • Nutrition Science

Background:

  • Self-reported food intolerances impact 15-20% of the population.
  • Histamine intolerance (HIT) is characterized by symptoms arising from a disequilibrium between dietary histamine intake and the body's ability to degrade it.
  • HIT is often linked to reduced activity of diamine oxidase (DAO), the primary enzyme responsible for histamine breakdown.

Purpose of the Study:

  • To explore the challenges in diagnosing histamine intolerance.
  • To review the current therapeutic strategies for managing HIT, focusing on dietary interventions.
  • To evaluate the potential role and efficacy of diamine oxidase (DAO) supplementation in HIT management.

Main Methods:

  • Diagnosis of HIT relies on clinical assessment and response to dietary modifications due to the absence of a validated biomarker.
  • Therapeutic strategies primarily involve dietary management, including the restriction of high-histamine foods.
  • Investigated the potential benefits of diamine oxidase (DAO) supplementation, considering factors influencing its activity.

Main Results:

  • The diagnosis of HIT remains challenging, primarily relying on clinical evaluation and dietary response.
  • Dietary management, while central to treatment, presents difficulties for patients.
  • DAO supplementation may offer a beneficial role in alleviating clinical manifestations of HIT, though clinical evidence is limited.

Conclusions:

  • Histamine intolerance is a complex condition influenced by dietary histamine and individual histamine degradation capacity.
  • Current management focuses on low-histamine diets, with DAO supplementation showing potential but requiring further clinical validation.
  • Further research is needed to establish definitive diagnostic markers and optimize therapeutic interventions for HIT.